During the past decade, Urology Clinics of North Texas conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 20 clinical trials were completed, i.e. on average, 87% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 11 clinical trials were completed. i.e. 157.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Urology Clinics of North Texas" #1 sponsor was "Ferring Pharmaceuticals" with 5 trials, followed by "Endo Pharmaceuticals" with 3 trials sponsored, "GTx" with 3 trials sponsored, "Pfizer" with 3 trials sponsored and "Allergan" with 3 trials sponsored. Other sponsors include 31 different institutions and companies that sponsored additional 34 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Urology Clinics of North Texas" #1 collaborator was "Astellas Pharma Inc" with 2 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 2 trials as a collaborator, "City of Hope Medical Center" with 1 trials as a collaborator, "Foundation Medicine" with 1 trials as a collaborator and "H2O Clinical LLC" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Urology Clinics of North Texas" are "Prostate Cancer" (14 trials), "Stress Urinary Incontinence" (5 trials), "Urinary Incontinence" (5 trials), "Bladder Cancer" (3 trials) and "Overactive Bladder" (3 trials). Many other conditions were trialed in "Urology Clinics of North Texas" in a lesser frequency.

Most popular intervention types in "Urology Clinics of North Texas" are "Drug" (37 trials), "Biological" (10 trials), "Other" (3 trials), "Device" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Degarelix" (3 trials), "Enzalutamide" (3 trials), "GTx-024" (2 trials) and "Vibegron" (2 trials). Other intervention names were less common.

The vast majority of trials in "Urology Clinics of North Texas" are 31 trials for "Male" genders, 16 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Urology Clinics of North Texas". undefined are not yet recruiting, 5 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Urology Clinics of North Texas, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Urology Clinics of North Texas, 2 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".